|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
The present study investigated the ability of human
choriodecidua to induce myometrial cell apoptosis through
the secretion of tumor necrosis factor alpha (TNF). The
secretion of TNF was evaluated in culture media from both
cultured amnion and choriodecidua explants exposed to the
bacterial endotoxin lipopolysaccharide (LPS) in order to
mimic an inflammation injury. The choriodecidua was more
responsive than the amnion in producing TNF when
stimulated with LPS despite choriodecidua lower level of
TLR4 expression. Moreover, conditioned medium obtained
from LPS-treated choriodecidua explants, but not amnion
explants, decreased the number of viable cultured
myometrial cells and induced cell apoptosis through
overexpression of the pro-apoptotic protein BAX and by
decreasing expression of the anti-apoptotic protein BCL2.
Neutralization of TNF in the choriodecidua-conditioned
medium reversed this effect. Exogenous TNF mimicked
LPS-treated choriodecidua-conditioned medium by inducing
myometrial cell apoptosis and by reducing expression of
BCL2 as well as increasing expression of BAX. By using
neutralizing antibody against both subtypes of TNF
receptors, we demonstrated that only TNFRSF1A participates
in TNF induced myometrial cell apoptosis. Our in vitro
model of LPS-induced inflammation of human fetal membrane
explants suggests a mechanism by which TNF, secreted by
choriodecidua, governs human myometrial cell apoptosis at
the end of pregnancy. Such data support the hypothesis
that TNF may participate to the complex network of
signaling processes associated with uterine involution.
Key words:
Pregnancy
Apoptosis
Cytokines
Placenta
Uterus
This article has been cited by other articles:
![]() |
R. Herve, T. Schmitz, D. Evain-Brion, D. Cabrol, M.-J. Leroy, and C. Mehats The PDE4 Inhibitor Rolipram Prevents NF-{kappa}B Binding Activity and Proinflammatory Cytokine Release in Human Chorionic Cells J. Immunol., August 1, 2008; 181(3): 2196 - 2202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |